MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $194.18 million. The enterprise value is $169.66 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MediWound has 10.88 million shares outstanding. The number of shares has increased by 16.23% in one year.
Current Share Class | 10.88M |
Shares Outstanding | 10.88M |
Shares Change (YoY) | +16.23% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | 1.74% |
Owned by Institutions (%) | 43.08% |
Float | 7.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 9.65 |
Forward PS | 6.83 |
PB Ratio | 9.64 |
P/TBV Ratio | 9.68 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 8.54 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.40.
Current Ratio | 1.48 |
Quick Ratio | 1.35 |
Debt / Equity | 0.40 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -148.65% and return on invested capital (ROIC) is -52.76%.
Return on Equity (ROE) | -148.65% |
Return on Assets (ROA) | -22.25% |
Return on Invested Capital (ROIC) | -52.76% |
Return on Capital Employed (ROCE) | -58.33% |
Revenue Per Employee | $178,901 |
Profits Per Employee | -$254,360 |
Employee Count | 111 |
Asset Turnover | 0.32 |
Inventory Turnover | 4.59 |
Taxes
In the past 12 months, MediWound has paid $82,000 in taxes.
Income Tax | 82,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.35% in the last 52 weeks. The beta is 0.25, so MediWound's price volatility has been lower than the market average.
Beta (5Y) | 0.25 |
52-Week Price Change | +4.35% |
50-Day Moving Average | 18.63 |
200-Day Moving Average | 18.32 |
Relative Strength Index (RSI) | 51.00 |
Average Volume (20 Days) | 159,547 |
Short Selling Information
Short Interest | 871,127 |
Short Previous Month | 801,204 |
Short % of Shares Out | 9.40% |
Short % of Float | n/a |
Short Ratio (days to cover) | 9.45 |
Income Statement
In the last 12 months, MediWound had revenue of $19.86 million and -$28.23 million in losses. Loss per share was -$2.63.
Revenue | 19.86M |
Gross Profit | 3.66M |
Operating Income | -22.12M |
Pretax Income | -12.55M |
Net Income | -28.23M |
EBITDA | -21.28M |
EBIT | -22.12M |
Loss Per Share | -$2.63 |
Full Income Statement Balance Sheet
The company has $32.44 million in cash and $8.07 million in debt, giving a net cash position of $24.37 million or $2.24 per share.
Cash & Cash Equivalents | 32.44M |
Total Debt | 8.07M |
Net Cash | 24.37M |
Net Cash Per Share | $2.24 |
Equity (Book Value) | 20.12M |
Book Value Per Share | 1.85 |
Working Capital | 14.01M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$15.26 million and capital expenditures -$4.01 million, giving a free cash flow of -$19.27 million.
Operating Cash Flow | -15.26M |
Capital Expenditures | -4.01M |
Free Cash Flow | -19.27M |
FCF Per Share | -$1.77 |
Full Cash Flow Statement Margins
Gross margin is 18.43%, with operating and profit margins of -111.41% and -142.18%.
Gross Margin | 18.43% |
Operating Margin | -111.41% |
Pretax Margin | -141.77% |
Profit Margin | -142.18% |
EBITDA Margin | -107.15% |
EBIT Margin | -111.41% |
FCF Margin | n/a |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.23% |
Shareholder Yield | -16.23% |
Earnings Yield | -14.55% |
FCF Yield | -9.93% |
Analyst Forecast
The average price target for MediWound is $35.00, which is 96.02% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $35.00 |
Price Target Difference | 96.02% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 41.96% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 1:7.
Last Split Date | Dec 20, 2022 |
Split Type | Reverse |
Split Ratio | 1:7 |
Scores
MediWound has an Altman Z-Score of -2.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.67 |
Piotroski F-Score | 2 |